Clerici G, Donti E, Zacutti A, Di Renzo G C
Centre of Perinatal Medicine, University of Perugia, Italy.
Eur J Hum Genet. 1997;5 Suppl 1:42-7.
In Italy, there are about 560,000 births per year. The number of prenatal diagnoses (PND) performed is estimated at 80,000 examinations per year, but no official data are available regarding the distribution of the different procedures. There are no official registers, either at a national or at a regional level, concerning PND and particularly the invasive procedures (as amniocentesis, chorionic villus sampling, chordocentesis). Thanks to the direct interest of some scientific societies, such as the Italian Association of Medical Cytogenetics, the Italian Association of Medical Genetics, the Italian Society for the Study of Metabolic Hereditary Diseases and the Italian Society of Gynaecology and Obstetrics, it has been possible to identify the number and distribution of public and private structures interested in genetic counselling and prenatal diagnosis during the last decades. As to the congenital malformations, there is a regional epidemiological system of surveys (started in 1982) co-ordinated by the Epidemiological and Biostatistical Laboratory of the 'Istituto Superiore di Sanità' (National Board of Health). This institution has published data for the period between 1986 and 1990 concerning the trend of incidence for the most important malformations at birth. Cytogenetic PND in public services is allowed for the following indications: maternal age 35 and over, previous child with a chromosomal anomaly, parent with a constitutional chromosomal abnormality and abnormal findings at the ultrasound examinations. Current methods in use consist in echography, amniocentesis, chorionic villus sampling, fetal blood sampling and maternal serum screening. At the moment, new approaches to the fetal tissue sampling are, as follows: amniotic fluid filtration, transcervical cell sampling and isolation of fetal cells from maternal blood. Furthermore, areas under development are 3D sonography and first-trimester anatomic survey sonography. PND is financed by regional laws, the National Health Service and private funds. There is a current legislation on termination of pregnancy (Law 194/1978). This law permits voluntary interruption of pregnancy within the first 90 days, while it is permitted between 90 and 180 days only in cases of severe fetal anomalies and over 180 days for serious risks for the woman's life: but it is necessary to do everything to save the fetal life. No law has been issued yet on pre-implantation diagnosis. Presently, the major problems are: the unbalanced distribution of financial resources among the different regions, the irrational number and distribution of centres for PND, inadequate prenatal counselling, especially in central/southern Italy, where counselling is somehow lacking. Therefore, guidelines for appropriate prenatal counselling should be established. For the future, we believe that the best results in this field are probably related to the advances of research (there is a target programme of the Italian National Research Council called 'Genetic Engineering', which is in its fourth year of financing). This programme will hopefully be cost-effective and improve the quality of PND so that more congenital anomalies can be detected at lower expenses in the future.
在意大利,每年约有56万例分娩。每年进行的产前诊断(PND)数量估计为8万例检查,但没有关于不同程序分布的官方数据。在国家或地区层面,均没有关于产前诊断,特别是侵入性程序(如羊膜穿刺术、绒毛取样、脐带穿刺术)的官方登记册。由于一些科学协会的直接关注,如意大利医学细胞遗传学协会、意大利医学遗传学协会、意大利代谢遗传性疾病研究协会以及意大利妇产科协会,在过去几十年中得以确定对遗传咨询和产前诊断感兴趣的公共和私人机构的数量及分布情况。关于先天性畸形,有一个由“国家卫生研究院”(国家卫生局)的流行病学和生物统计学实验室协调的地区性流行病学调查系统(始于1982年)。该机构公布了1986年至1990年期间最重要的出生畸形发病率趋势数据。公共服务中的细胞遗传学产前诊断适用于以下指征:孕妇年龄35岁及以上、前一个孩子有染色体异常、父母有先天性染色体异常以及超声检查有异常发现。目前使用的方法包括超声检查、羊膜穿刺术、绒毛取样、胎儿血液取样和母体血清筛查。目前,胎儿组织取样的新方法如下:羊水过滤、经宫颈细胞取样以及从母体血液中分离胎儿细胞。此外,正在发展的领域包括三维超声检查和孕早期解剖学超声检查。产前诊断由地区法律、国家卫生服务机构和私人基金提供资金。目前有关于终止妊娠的立法(第194/1978号法律)。该法律允许在怀孕的前90天内自愿终止妊娠,而仅在严重胎儿异常的情况下允许在90至180天之间终止妊娠,对于危及妇女生命的严重风险则允许在180天以上终止妊娠:但必须尽一切努力挽救胎儿生命。目前尚未发布关于植入前诊断的法律。目前,主要问题包括:不同地区财政资源分配不均衡、产前诊断中心数量和分布不合理、产前咨询不足,尤其是在意大利中部/南部地区,那里的咨询在某种程度上有所欠缺。因此,应制定适当的产前咨询指南。对于未来,我们认为该领域的最佳成果可能与研究进展相关(意大利国家研究委员会有一个名为“基因工程”的目标计划正在进行第四年的资助)。该计划有望具有成本效益并提高产前诊断的质量,以便未来能够以更低的成本检测出更多的先天性异常。